Successful implementation of a nurse-led teaching programme to independently administer subcutaneous methotrexate in the community setting to children with Crohn's disease

Alimentary Pharmacology and Therapeutics

Volumn 29, Issue 1, 2009, Pages 90-96

  Garrick, V ^a   Atwal, P ^a   Barclay, A R ^b   McGrogan, P ^a   Russell, R K ^a  

^a ROYAL HOSPITAL FOR SICK CHILDREN   (United Kingdom)

^b UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DOMPERIDONE; METHOTREXATE; ONDANSETRON;

ADOLESCENT; ADULT; ARTICLE; CHILD; CLINICAL ARTICLE; COST CONTROL; CROHN DISEASE; DRUG DOSE REDUCTION; FEMALE; HUMAN; LIVER DISEASE; MALE; MONEY; NAUSEA; NEUTROPENIA; NORMAL HUMAN; NURSE; PATIENT EDUCATION; PATIENT TRANSPORT; PRIORITY JOURNAL; SCHOOL CHILD; TRANSAMINITIS; VOMITING;

ADOLESCENT; CHILD; CROHN DISEASE; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INJECTIONS, SUBCUTANEOUS; MALE; METHOTREXATE; NURSE CLINICIANS; PARENTS; RESIDENCE CHARACTERISTICS; RETROSPECTIVE STUDIES; SCOTLAND; TREATMENT OUTCOME;

EID: 57649175017     PISSN: 02692813     EISSN: 13652036     Source Type: Journal    
DOI: 10.1111/j.1365-2036.2008.03861.x     Document Type: Article

References (33)

1. Podolsky DK. Inflammatory bowel disease. N Engl J Med 2002 347 : 417 29.
2. Armitage E, Drummond H, Ghosh S, Ferguson A. Incidence of juvenile-onset Crohn's disease in Scotland. Lancet 1999 353 : 1496 7.
3. Barton JR, Gillon S, Ferguson A. Incidence of inflammatory bowel disease in Scottish children between 1968 and 1983; marginal fall in ulcerative colitis, three-fold rise in Crohn's disease. Gut 1989 30 : 618 22.
4. Sawczenko A, Sandhu BK, Logan RF, et al. Prospective survey of childhood inflammatory bowel disease in the British Isles. Lancet 2001 357 : 1093 4.
5. Economou M, Pappas G. New global map of Crohn's disease: genetic, environmental and socioeconomic correlations. Inflamm Bowel Dis 2008 14 : 709 20.
6. Wilson DC, IBD Working Group. Development of evidence-based guidelines for paediatric inflammatory bowel disease: currently impossible due to lack of relevant evidence! Arch Dis Child 2008 93 (Suppl 1 A18.
7. Benchimol EI, Seow CH, Steinhart AH, Griffiths AM. Traditional corticosteroids for induction of remission in Crohn's disease. Cochrane Database Syst Rev 2008 2 : CD006792.
8. Dziechciarz P, Horvath A, Shamir R, Szajewska H. Meta-analysis: enteral nutrition in active Crohn's disease in children. Aliment Pharmacol Ther 2007 26 : 795 806.
9. Steinhart AH, Ewe K, Griffiths AM, Modigliani R, Thomsen OO. Corticosteroids for maintenance of remission in Crohn's disease. Cochrane Database Syst Rev 2003 4 : CD000301.
10. Russell RK, Van Limbergen J, Drummond HE, et al. Definition of phenotypic characteristics of childhood-onset inflammatory bowel disease. Gastroenterology 2008 135 : 1114 22.
11. Markowitz J, Grancher K, Kohn N, Lesser M, Daum F. A multicenter trial of 6-mercaptopurine and prednisone in children with newly diagnosed Crohn's disease. Gastroenterology 2000 119 : 895 902.
12. Kozarek RA, Patterson DJ, Gelfand MD, Botoman VA, Ball TJ, Wilske KR. Methotrexate induces clinical and histologic remission in patients with refractory inflammatory bowel disease. Ann Intern Med 1989 110 : 353 6.
13. Feagan BG, Rochon J, Fedorak RN, et al. Methotrexate for the treatment of Crohn's disease. The North American Crohn's Study Group Investigators. N Engl J Med 1995 332 : 292 7.
14. Turner D, Grossman AB, Rosh J, et al. Methotrexate following unsuccessful thiopurine therapy in pediatric Crohn's disease. Am J Gastroenterol 2007 102 : 2804 12.
15. Feagan BG, Fedorak RN, Irvine EJ, et al. A comparison of methotrexate with placebo for the maintenance of remission in Crohn's disease. North American Crohn's Study Group Investigators. N Engl J Med 2000 342 : 1627 32.
16. Mahadevan U, Marion JF, Present DH. Fistula response to methotrexate in Crohn's disease: a case series. Aliment Pharmacol Ther 2003 18 : 1003 8.
17. Soon SY, Ansari A, Yaneza M, Raoof S, Hirst J, Sanderson JD. Experience with the use of low-dose methotrexate for inflammatory bowel disease. Eur J Gastroenterol Hepatol 2004 16 : 921 6.
18. Mack DR, Young R, Kaufman SS, Ramey L, Vanderhoof JA. Methotrexate in patients with Crohn's disease after 6-mercaptopurine. J Pediatr 1998 132 : 830 5.
19. Ravikumara M, Hinsberger A, Spray CH. Role of methotrexate in the management of Crohn disease. J Pediatr Gastroenterol Nutr 2007 44 : 427 30.
20. Uhlen S, Belbouab R, Narebski K, et al. Efficacy of methotrexate in pediatric Crohn's disease: a French multicenter study. Inflamm Bowel Dis 2006 12 : 1053 7.
21. Akobeng A. Crohn's disease: current treatment options. Arch Dis Child 2008 93 : 787 92.
22. Lennard-Jones JE. Classification of inflammatory bowel disease. Scand J Gastroenterol 1989 170 : 2 6.
23. IBD Working Group of the European Society for Paediatric Gastroenterology HaN. Inflammatory bowel disease in children and adolescents: recommendations for diagnosis - the Porto criteria. J Pediatr Gastroenterol Nutr 2005 41 : 1 7.
24. Silverberg MS, Satsangi J, Ahmad T, et al. Towards an integrated clinical, molecular and serological classification of inflammatory bowel disease: Report of a Working Party of the 2005 Montreal World Congress of Gastroenterology. Can J Gastroenterol 2005 19 (Suppl. A 5 36.
25. Royal College of Nursing. Administering Subcutaneous Methotrexate for Inflammatory Arthritis: Guidance for Nurses. 2004. Available at: http://www.rcn.org.uk/__data/assets/pdf_file/0011/78608/002269.pdf (accessed September 2008), 28-32.
26. Livermore P. Teaching home administration of sub-cutaneous methotrexate. Paediatr Nurs 2003 15 : 28 32.
27. Nathan DM, Iser JH, Gibson PR. A single center experience of methotrexate in the treatment of Crohn's disease and ulcerative colitis: a case for subcutaneous administration. J Gastroenterol Hepatol 2008 23 : 954 8.
28. Clark CA, Mehta BH, Pruchnicki MC, Rodis JL. The pharmacist's role in teaching methotrexate injection for patients with Crohn's disease. Am J Health Syst Pharm 2006 63 : 1792 4.
29. Alfadhli AA, McDonald JW, Feagan BG. Methotrexate for induction of remission in refractory Crohn's disease. Cochrane Database Syst Rev 2005 1 : CD003459.
30. Din S, Dahele A, Fennel J, et al. Use of methotrexate in refractory Crohn's disease: the Edinburgh experience. Inflamm Bowel Dis 2008 14 : 756 62.
31. Domenech E, Manosa M, Navarro M, et al. Long-term methotrexate for Crohn's disease: safety and efficacy in clinical practice. J Clin Gastroenterol 2008 42 : 395 9.
32. Kurnik D, Loebstein R, Fishbein E, et al. Bioavailability of oral vs. subcutaneous low-dose methotrexate in patients with Crohn's disease. Aliment Pharmacol Ther 2003 18 : 57 63.
33. Stephens MC, Baldassano RN, York A, et al. The bioavailability of oral methotrexate in children with inflammatory bowel disease. J Pediatr Gastroenterol Nutr 2005 40 : 445 9.